H1N1 Inflnenza A Vaccine (Split,Virion),Inactivated (Changchun institute of biological products)

甲型H1N1流感病毒裂解疫苗（长春生物制品研究所）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameH1N1 Inflnenza A Vaccine (Split,Virion),Inactivated (Changchun institute of biological products)
Drug Alias NameInfluenza virus split vaccine (type A H1N1, Changchun institute of biological products)流感病毒裂解疫苗（甲型H1N1，长春生物制品研究所）
ClassificationVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaInfluenza, Human
Original Approved Country/TerritoryMainland China
Original Approved Date2009/09/18
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChangchun Institute Of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChangchun Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeJ07BB02
Related LinksN/A